Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old)
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of nelarabine-based consolidation and
maintenance therapy in term of relapse-free survival (RFS) in high-risk (HR) patients.